|
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial |
|
|
|
Titel: |
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial |
Auteur: |
Prince, H Miles Kim, Youn H Horwitz, Steven M Dummer, Reinhard Scarisbrick, Julia Quaglino, Pietro Zinzani, Pier Luigi Wolter, Pascal Sanches, Jose A Ortiz-Romero, Pablo L Akilov, Oleg E Geskin, Larisa Trotman, Judith Taylor, Kerry Dalle, Stephane Weichenthal, Michael Walewski, Jan Fisher, David Dréno, Brigitte Stadler, Rudolf Feldman, Tatyana Kuzel, Timothy M Wang, Yinghui Palanca-Wessels, Maria Corinna Zagadailov, Erin Trepicchio, William L Zhang, Wenwen Lin, Hui-Min Liu, Yi Huebner, Dirk Little, Meredith Whittaker, Sean Duvic, Madeleine |
Verschenen in: |
Lancet |
Paginering: |
Jaargang 390 (2017) nr. 10094 pagina's 12 p. |
Jaar: |
2017 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|